TheStreet
Your browser is not supported. Please upgrade to one of the following browsers:

Google Chrome

Mozilla Firefox

Apple Safari

Microsoft Internet Explorer 9+

You may proceed to the site by clicking here, however some pages might not work correctly.
ip-192-168-70-11
JOIN JIM CRAMER'S INVESTING CLUB
  • Log In
    Your Account
    Account Preferences Newsletters Alerts
    Logout
  • Newsletters
  • Subscribe
    Access insights and guidance from our Wall Street pros. Find the product that's right for you.
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement Daily
    • Stocks Under $10
    • Top Stocks
    • Trifecta Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • Jim Cramer
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • Investing
    • Earnings
    • Funds
    • Bitcoin
    • Fixed Income
    • Options
    • Futures
    • Stocks
    • ETFs
  • Personal Finance
    • Credit Cards
    • Debt Management
    • Mortgages
    • Real Estate
    • Taxes
    • Education
    • Savings
    • Insurance
  • Retirement
    • Social Security
    • Estate Planning
    • IRAs
    • 401k
  • Technology
    • Cybersecurity
  • Markets
    • Currencies
    • Rates and Bonds
    • Commodities
    • Emerging Markets
    • Mergers and Acquisitions
    • IPOs
    • Bankruptcy
    • Regulation
    • Corporate Governance
  • How-To
  • Video
TheStreet Ratings

Research Center
Reports
Stock Upgrades & Downgrades

Sanofi

Find Ratings Reports
SNY : NASDAQ : Health Technology
$45.32 -0.62 | -1.30%
Today's Range: 45.24 - 45.53
Avg. Daily Volume: 1,737,100
03/03/21 - 10:24 AM ET
Rating Summary Rating Detail Financial Analysis Peer Group

Financial Analysis


SANOFI's gross profit margin for the third quarter of its fiscal year 2020 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its subsector this quarter as compared to the same quarter a year ago.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY20 Q3 FY19
Net Sales ($mil)12467.19976.45
EBITDA ($mil)0.00.0
EBIT ($mil)3479.882669.72
Net Income ($mil)2745.21875.74


Balance Sheet Q3 FY20 Q3 FY19
Cash & Equiv. ($mil)0.00.0
Total Assets ($mil)0.00.0
Total Debt ($mil)0.00.0
Equity ($mil)0.00.0


Profitability Q3 FY20 Q3 FY19
Gross Profit Margin63.7663.16
EBITDA Margin0.00.0
Operating Margin27.9126.76
Sales Turnover0.00.0
Return on Assets0.00.0
Return on Equity0.00.0
Debt Q3 FY20 Q3 FY19
Current Ratio0.00.0
Debt/Capital0.00.0
Interest Expense116.52107.25
Interest Coverage29.8624.89


Share Data Q3 FY20 Q3 FY19
Shares outstanding (mil)2512.382504.04
Div / share0.00.0
EPS1.080.8
Book value / share0.00.0
Institutional Own % n/a n/a
Avg Daily Volume2728773.01128281.0

Valuation


BUY. SANOFI's P/E ratio indicates a significant discount compared to an average of 48.11 for the Chemical Manufacturing subsector and a significant discount compared to the S&P 500 average of 39.72. The price-to-sales ratio is below the S&P 500 average and is well below the subsector average, indicating a discount. After reviewing these and other key valuation criteria, SANOFI proves to trade at a discount to investment alternatives.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
SNY 8.73 Peers 27.60   SNY NA Peers 19.66

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

SNY is trading at a significant discount to its peers.

 

Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
SNY 10.62 Peers 17.28   SNY 0.05 Peers 0.62

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

SNY is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

SNY trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
SNY NA Peers 10.13   SNY 283.94 Peers 8.34

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

Ratio not available.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

SNY is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
SNY 2.59 Peers 12.64   SNY 10.47 Peers 38.41

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

SNY is trading at a significant discount to its subsector on this measurement.

 

Lower. A sales growth rate that trails the subsector implies that a company is losing market share.

SNY significantly trails its peers on the basis of sales growth.

 

 

Latest Stock Upgrades/Downgrades

View more upgrades/downgrades >>
Ratings Guide
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • Video
  • Opinion
  • Politics
  • Lifestyle

Featured Topics

  • Mad Money
  • Stock Market Today
  • Dow Jones Today
  • Stocks
  • Funds
  • ETFs
  • Bitcoin
  • Travel
  • Sports
  • Health
  • Food and Drink
  • Cybersecurity
  • Penny Stocks
  • How to Invest in Stocks
  • Social Security
  • 401K
  • IRAs
  • Taxes
  • Index Funds
  • Roth IRAs
  • Home Insurance
  • Health Insurance
  • Disability Insurance
  • Prime Day

Popular Pages

  • Best Stocks
  • Best Stocks to Buy
  • Earnings Calendar
  • Ex Dividend Date
  • Mutual Fund Ratings
  • Best Online Brokers
  • Rates and Bonds
  • Commodities
  • Treasury Bonds
  • Junk Bonds
  • Corporate Bonds
  • Municipal Bonds

Subscriptions

  • Action Alerts PLUS
  • Quant Ratings
  • Real Money
  • Real Money Pro
  • Retirement Daily
  • Stocks Under $10
  • Top Stocks
  • Trifecta Stocks
  • RMP Portfolio
  • Chairman's Club

Stay Connected

  • Sitemap
  • Feedback
  • About Us
  • Investor Relations
  • Advertise
  • Reprints
  • Customer Service
  • Employment
  • Privacy Policy
  • Terms of Use
  • Topic Archive
  • Video Sitemap
  • Data
  • Affiliate
  • Press Room
© 1996- TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.

  • INVEST WITH CRAMER FREE for 14 Days→
    • Jim Cramer
      • Action Alerts PLUS
      • Cramer's Blog
      • Cramer's Monthly Call
      • Jim Cramer's Best Stocks
      • Cramer's Articles
      • Mad Money
      • 25 Rules for Investing
      • 10 Commandments
    • Investing
      • Earnings
      • Funds
      • Bitcoin
      • Fixed Income
      • Options
      • Futures
      • Stocks
      • ETFs
    • Personal Finance
      • Credit Cards
      • Debt Management
      • Mortgages
      • Real Estate
      • Taxes
      • Education
      • Savings
      • Insurance
    • Retirement
      • Social Security
      • Estate Planning
      • IRAs
      • 401k
    • Technology
      • Cybersecurity
    • Markets
      • Currencies
      • Rates and Bonds
      • Commodities
      • Emerging Markets
      • Mergers and Acquisitions
      • IPOs
      • Bankruptcy
      • Regulation
      • Corporate Governance
    • How-To
    • Video
    Privacy Policy|Terms of Use
    © 1996-2018 TheStreet Inc. All rights reserved